Postdoctoral Training Program in Pulmonary and Critical Care Translational Research

肺部和重症监护转化研究博士后培训项目

基本信息

  • 批准号:
    10198029
  • 负责人:
  • 金额:
    $ 34.19万
  • 依托单位:
  • 依托单位国家:
    美国
  • 项目类别:
  • 财政年份:
    2019
  • 资助国家:
    美国
  • 起止时间:
    2019-07-01 至 2024-06-30
  • 项目状态:
    已结题

项目摘要

Project Summary/Abstract We enthusiastically submit this revised application for our T32 training program here at the University of Illinois at Chicago (UIC) entitled Postdoctoral Training Program in Pulmonary and Critical Care Translational Research. The primary goal of our program is the career development of the next generation of scientific leaders in the fields of pulmonary and critical care medicine along three integrated thematic pathways that provide comprehensive training in 1) Lung Injury and Inflammation, 2) Precision Medicine and Computational Approaches, and 3) Comparative Effectiveness and Health Inequality. This innovative new program builds upon our experience and success achieved over a recent 10 year period with a prior postdoctoral T32 based here in our Division of Pulmonary, Critical Care, Sleep, and Allergy. This prior program had an outstanding trajectory of success, with our recent T32 trainees earning 3 new K08s, 1 K23, and 1 R01 in the past two years alone. Moreover, 13 out of the last 18 T32 fellows in our prior program continue to pursue scientifically-oriented careers. With this new program, we build upon this impressive history of success and have substantially advanced and expanded our training environment through the recruitment of multiple new faculty. The addition of their various areas of scientific expertise brings new state-of-the-art dimensions to our training environment. Our underlying premise and unifying hypothesis is that an integrated program focused on cutting-edge research approaches will inspire a new generation of successful scientific leaders in lung diseases. With frequent input and feedback from faculty, trainees, and internal and external advisors, we continually enhance and improve our training program to optimize the career development and scientific success of our trainees. Major programmatic enhancements in this new program include the following:  Faculty expansion and development have added training opportunities in multiple new fields—lung microbiome, sarcoidosis, lung cancer, precision medicine, computational modeling, healthcare design, population health science  Transition to a multi-PI leadership structure to optimize program oversight and growth  Detailed description of current training timeline and trainee milestones  Formation of a Minority Advisory Committee  Incorporation of former T32 trainees and junior faculty into the program as “near peer” advisors  Required training in scientific rigor and reproducibility for T32 trainees  Expanded annual training in mentorship that is required for faculty  Incorporation of a PhD Training Committee to enhance recruitment and training of PhD candidates  “360 degree evaluation” with emphasis on current and former trainee program reviews at annual retreat Candidates will be accepted for 2-3 years of research training based on exceptional personal qualifications.
项目摘要/摘要 我们热情地在伊利诺伊大学AT的T32培训计划中提交了这项修订的申请 芝加哥(UIC)题为《肺和重症监护术的博士后培训计划》 研究。我们计划的主要目标是下一代科学领导者的职业发展 在沿着三个提供的综合主题途径的肺和重症监护医学领域 1)肺部损伤和炎症的全面训练,2)精密医学和计算方法, 3)比较有效性和健康不平等。这个创新的新计划以我们的经验为基础 并在最近的10年期间取得了成功,以前的博士后T32基于我们的部门 肺,重症监护,睡眠和过敏。这个先前的计划具有成功的杰出轨迹,并 仅在过去的两年中,我们最近的T32实习生赢得了3个新的K08,1 K23和1 R01。而且,13岁 在我们先前的计划中的最后18个T32研究员中,继续从事以科学为导向的职业。有了这个新的 计划,我们基于这一令人印象深刻的成功历史,并大大提高并扩展了我们的 通过招募多个新教师培训环境。增加了他们的科学领域 专业知识为我们的培训环境带来了新的最先进维度。我们的基本前提和 统一的假设是一个专注于尖端研究方法的综合计划将 激发了新一代成功的肺部疾病科学领袖。经常输入和反馈 从教师,学员以及内部和外部顾问中,我们不断增强和改善我们的培训计划 优化学员的职业发展和科学成功。主要的编程增强 该新程序包括以下内容: 教师的扩张和发展增加了在多个新领域的培训机会 - 肺 微生物组,结节病,肺癌,精密医学,计算建模,医疗保健设计, 人口健康科学 过渡到多PI领导结构以优化计划的监督和增长 当前培训时间表和学员里程碑的详细说明 成立少数民族咨询委员会 将前T32学员和初级教师纳入该计划,作为“近乎同行”顾问 需要对T32受训者进行科学严格和可重复性的培训 扩大教职员工所需的年度培训 成立博士培训委员会,以增强候选人的招聘和培训 “ 360度评估”,重点是年度务虚会的当前和前任实习计划评论 基于卓越的个人资格,将接受候选人2 - 3年的研究培训。

项目成果

期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)

暂无数据

数据更新时间:2024-06-01

STEVEN M DUDEK的其他基金

Pathobiology of MRSA-induced Endothelial Permeability and Acute Lung Injury
MRSA 诱导的内皮通透性和急性肺损伤的病理学
  • 批准号:
    10608606
    10608606
  • 财政年份:
    2022
  • 资助金额:
    $ 34.19万
    $ 34.19万
  • 项目类别:
Patient Sampling and Genomics Core
患者采样和基因组学核心
  • 批准号:
    10701927
    10701927
  • 财政年份:
    2021
  • 资助金额:
    $ 34.19万
    $ 34.19万
  • 项目类别:
Patient Sampling and Genomics Core
患者采样和基因组学核心
  • 批准号:
    10491060
    10491060
  • 财政年份:
    2021
  • 资助金额:
    $ 34.19万
    $ 34.19万
  • 项目类别:
Fostering Academic Physician-Investigators Treating High Risk Populations
培养治疗高危人群的学术医师研究人员
  • 批准号:
    10647841
    10647841
  • 财政年份:
    2021
  • 资助金额:
    $ 34.19万
    $ 34.19万
  • 项目类别:
Fostering Academic Physician-Investigators Treating High Risk Populations
培养治疗高危人群的学术医师研究人员
  • 批准号:
    10459247
    10459247
  • 财政年份:
    2021
  • 资助金额:
    $ 34.19万
    $ 34.19万
  • 项目类别:
Patient Sampling and Genomics Core
患者采样和基因组学核心
  • 批准号:
    10170862
    10170862
  • 财政年份:
    2021
  • 资助金额:
    $ 34.19万
    $ 34.19万
  • 项目类别:
Postdoctoral Training Program in Pulmonary and Critical Care Translational Research
肺部和重症监护转化研究博士后培训项目
  • 批准号:
    10472480
    10472480
  • 财政年份:
    2019
  • 资助金额:
    $ 34.19万
    $ 34.19万
  • 项目类别:
Postdoctoral Training Program in Pulmonary and Critical Care Translational Research
肺部和重症监护转化研究博士后培训项目
  • 批准号:
    10700843
    10700843
  • 财政年份:
    2019
  • 资助金额:
    $ 34.19万
    $ 34.19万
  • 项目类别:
Postdoctoral Training Program in Pulmonary and Critical Care Translational Research
肺部和重症监护转化研究博士后培训项目
  • 批准号:
    9791769
    9791769
  • 财政年份:
    2019
  • 资助金额:
    $ 34.19万
    $ 34.19万
  • 项目类别:
Crosstalk between S1P Receptor 1/S1P1 and P-Selectin/Selp in Regulation of Inflammatory Vascular Permeability
S1P 受体 1/S1P1 和 P-选择素/Selp 之间的串扰调节炎症血管通透性
  • 批准号:
    10871784
    10871784
  • 财政年份:
    2016
  • 资助金额:
    $ 34.19万
    $ 34.19万
  • 项目类别:

相似国自然基金

剪接因子SNRPA1通过调节R-loop稳态影响肺腺癌发展进程的机制研究
  • 批准号:
    32360143
  • 批准年份:
    2023
  • 资助金额:
    32 万元
  • 项目类别:
    地区科学基金项目
布洛芬通过线粒体超极化损伤早产儿肺血管发育的机制及干预研究
  • 批准号:
    82371707
  • 批准年份:
    2023
  • 资助金额:
    65 万元
  • 项目类别:
    面上项目
基于“阳虚阴结”理论探讨甘草干姜汤通过Sirt1调控PI3K/Akt信号通路抑制肺成纤维细胞增殖干预RA-ILD的机制研究
  • 批准号:
    82305166
  • 批准年份:
    2023
  • 资助金额:
    30 万元
  • 项目类别:
    青年科学基金项目
间质性肺疾病致肺气体交换功能改变的超极化129Xe MRI定量研究
  • 批准号:
    82372150
  • 批准年份:
    2023
  • 资助金额:
    48 万元
  • 项目类别:
    面上项目
ACSS2介导的乙酰辅酶a合成在巨噬细胞组蛋白乙酰化及急性肺损伤发病中的作用机制研究
  • 批准号:
    82370084
  • 批准年份:
    2023
  • 资助金额:
    48 万元
  • 项目类别:
    面上项目

相似海外基金

Utilizing induced pluripotent stem cells to study the role of alveolar type 2 cell dysfunction in pulmonary fibrosis
利用诱导多能干细胞研究肺泡2型细胞功能障碍在肺纤维化中的作用
  • 批准号:
    10591174
    10591174
  • 财政年份:
    2023
  • 资助金额:
    $ 34.19万
    $ 34.19万
  • 项目类别:
A Novel Training Intervention to Improve Provider Management of Sleep Apnea in Rural Communities
改善农村社区睡眠呼吸暂停提供者管理的新型培训干预措施
  • 批准号:
    10592026
    10592026
  • 财政年份:
    2023
  • 资助金额:
    $ 34.19万
    $ 34.19万
  • 项目类别:
Determinants of long-term outcomes and heterogeneity in Gram-negative community-acquired pneumonia
革兰氏阴性社区获得性肺炎长期结局和异质性的决定因素
  • 批准号:
    10676010
    10676010
  • 财政年份:
    2023
  • 资助金额:
    $ 34.19万
    $ 34.19万
  • 项目类别:
An Alternative Pathobiology underlying Severe Asthma
严重哮喘的替代病理学
  • 批准号:
    10736884
    10736884
  • 财政年份:
    2023
  • 资助金额:
    $ 34.19万
    $ 34.19万
  • 项目类别:
Sustainable Implementation of Prone Positioning for the Acute Respiratory Distress Syndrome
持续实施俯卧位治疗急性呼吸窘迫综合征
  • 批准号:
    10722194
    10722194
  • 财政年份:
    2023
  • 资助金额:
    $ 34.19万
    $ 34.19万
  • 项目类别: